Company Overview of APT Pharmaceuticals, Inc.
APT Pharmaceuticals, Inc. engages in the development of cyclosporine inhalation solution for the prevention of chronic rejection in lung transplantation. Its cyclosporine inhalation solution is an inhaled formulation of cyclosporine A, an oral medication is used to prevent rejection in solid organ transplant recipients. The company was founded in 1999 and is based in Burlingame, California.
700 Airport Boulevard
Burlingame, CA 94010
Founded in 1999
Key Executives for APT Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Bachem, Inc.||United States|
|Miza Pharmaceuticals USA||United States|
|Midway Pharmaceuticals Inc.||United States|
|CBA Pharma, Inc.||United States|
|PharmPro Services||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact APT Pharmaceuticals, Inc., please visit www.aptbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.